Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVMD | ALNY | RPRX | ||
| Company | Revolution Medicines Inc | Alnylam Pharmaceuticals | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 153.69 | 293.40 | 53.84 | ||
| High | 155.76 | 299.98 | 54.68 | ||
| Low | 150.95 | 292.91 | 53.50 | ||
| Latest | 153.00 | 295.63 | 53.97 | ||
| Change | -1.89 | +0.13 | +0.11 | ||
| % Change | -1.22% | +0.04% | +0.20% | ||
| Volume | 2,881,800 | 629,500 | 3,075,800 | ||
| 20-Day Average Volume | 2,355,285 | 1,028,720 | 3,581,690 | ||
| Previous Close | 154.89 | 295.50 | 53.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 147.24 | 295.84 | 51.88 | ||
| 20-Day Raw Stochastic | 81.45% | 34.11% | 86.32% | ||
| 20-Day Relative Strength | 61.86 | 44.78 | 67.50 | ||
| Weighted Alpha | +138.99 | -16.26 | +69.28 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.87% since 05/19/26 | +0.45% since 05/19/26 | +2.98% since 05/19/26 | ||
| Low | 148.02 on 05/20/26 | 292.10 on 05/20/26 | 52.50 on 05/21/26 | ||
| High | 156.24 on 05/22/26 | 303.33 on 05/22/26 | 54.74 on 05/26/26 | ||
| 1-Month | |||||
| %Chg | +16.20% since 04/27/26 | -4.17% since 04/27/26 | +8.70% since 04/27/26 | ||
| Low | 138.75 on 04/30/26 | 284.28 on 05/11/26 | 49.11 on 05/04/26 | ||
| High | 156.24 on 05/22/26 | 317.55 on 04/30/26 | 54.74 on 05/26/26 | ||
| 3-Month | |||||
| %Chg | +49.97% since 02/27/26 | -11.20% since 02/27/26 | +16.79% since 02/27/26 | ||
| Low | 91.52 on 03/30/26 | 284.28 on 05/11/26 | 44.73 on 03/20/26 | ||
| High | 156.24 on 05/22/26 | 343.36 on 04/14/26 | 54.74 on 05/26/26 | ||
| 6-Month | |||||
| %Chg | +97.22% since 11/26/25 | -33.58% since 11/26/25 | +35.47% since 11/26/25 | ||
| Low | 73.00 on 12/16/25 | 284.28 on 05/11/26 | 37.83 on 12/16/25 | ||
| High | 156.24 on 05/22/26 | 479.79 on 12/03/25 | 54.74 on 05/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,928,992 | 39,453,092 | 31,014,310 | ||
| Shares Outstanding, K | 212,596 | 133,513 | 575,832 | ||
| Annual Sales | 0 | 3,713,940,000 | 2,378,190,000 | ||
| Annual Net Income | -1,131,300,000 | 313,750,000 | 770,950,000 | ||
| Last Quarter Sales | 0 | 1,167,180,000 | 630,580,000 | ||
| Last Quarter Net Income | -453,820,000 | 205,990,000 | 294,690,000 | ||
| 60-Month Beta | 1.41 | 0.31 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.29 on 05/06/26 | 1.99 on 04/30/26 | 1.30 on 05/06/26 | ||
| Earnings Date | 08/05/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | 0.235 on 05/15/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/15/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 81.49 | 10.75 | ||